Portfolio, Licensing & Development Strategy

New drug commercial assessment – identifying the best opportunity for phase III investment.

Our client sought to fully understand the market opportunity of their product across 5 widely different potential indications, which spanned from rare nephrology to dermatological conditions.

We quantified this opportunity both scientifically, clinically, and commercially across all indications, to provide a clear business case for the prioritisation of the indications based on overall commercial and clinical opportunity and feasibility.

Testimonial about Portfolio, Licensing & Development Strategy 1